Pfizer, Inc. Financial Ratios — PFIZ34 Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	11.78	17.83	27.94	12.38	10.24	11.62	32.58	16.56	25.33	14.5	31.3	36.3	2.29	9.06	8.9
Return on Assets (%)	5.23	7.8	12.3	5.38	4.16	4.26	12.41	6.73	9.8	5.69	13.09	16.57	1	3.65	3.69
Return on Capital (%)	8.76	13.1	19.77	9.14	7.46	8.07	- -	- -	15.95	9.72	21.39	26.47	- -	- -	- -
Return on Invested Capital (%)	6.61	8.09	9.86	8.07	7.1	6.64	- -	- -	9.61	5.4	16.16	25.65	- -	- -	- -
Gross Margin (%)	79.52	82.03	81.42	80.69	80.25	76.67	78.63	77.99	80.31	79.63	62.08	66.05	58.1	71.94	74.33
EBITDA Margin (%)	35	36.34	43.1	35.36	30.26	25.67	34.71	21.2	41.39	26.1	29.79	39.66	7.21	25.28	23.71
Operating Margin (%)	27.54	31.24	31.73	27.21	26.56	25.95	26.78	16.48	17.87	22.84	29.16	37.67	7.42	23.48	27.82
Incremental Operating Margin (%)	- -	- -	23.04	144.87	69.36	18.47	- -	62.65	726.25	295.17	35.8	72.47	80.97	258.31	- -
Pretax Margin (%)	18.81	20.57	30.47	24.67	18.35	15.81	23.42	8.8	27.68	16.89	29.91	34.33	1.78	12.61	12.02
Profit Margin (%)	16.4	26.66	42.65	18.42	14.25	13.66	40.55	27.32	39.18	21.99	27.04	31.01	3.56	12.62	12.42
Net Income to Common Margin (%)	16.4	26.65	42.65	18.41	14.25	13.66	40.55	27.32	39.18	21.99	27.04	31.01	3.56	12.62	12.42
Effective Tax Rate (%)	31.54	19.76	27.4	25.49	22.2	13.45	- -	- -	5.15	5.26	7.62	9.58	- -	- -	- -
Dvd Payout Ratio (%)	78.91	72.2	57.31	72.22	99.13	100.79	35.79	204.75	74.7	125.93	38.79	28.58	418.23	117.69	124.82
Sustainable Growth Rate (%)	2.48	4.96	11.93	3.44	0.09	-0.09	20.92	-17.35	6.41	-3.76	19.16	25.93	-7.3	-1.6	-2.21

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	38,942	37,460	36,489	36,682	37,605	41,062	42,606	41,265	50,840	38,274	36,998	34,859	70,845	63,649	63,961
ST Debt	4,016	6,424	6,027	5,141	10,159	10,663	9,940	8,836	16,190	2,703	2,241	2,934	10,346	6,946	3,154
LT Debt	34,926	31,036	30,462	31,541	27,446	30,399	32,666	32,429	34,650	35,571	34,757	31,925	60,499	56,703	60,807
Total Debt/EBITDA	1.82	1.89	1.64	2.09	2.54	3.03	2.34	4.77	3	3.52	1.53	0.87	16.5	3.96	4.31
Net Debt/EBITDA	1.67	1.38	1.54	1.9	2.3	2.84	2.26	4.64	2.94	3.36	1.45	0.86	15.83	3.89	4.23
Total Debt/EBIT	3.16	3.07	2.31	3.06	3.91	5.26	3.56	16.47	4.55	6.18	1.94	0.99	-35.49	7.01	7.76
Net Debt/EBIT	2.9	2.24	2.17	2.78	3.53	4.93	3.45	16.01	4.45	5.89	1.84	0.98	-34.06	6.9	7.62
EBITDA to Interest Expense	12.71	13.05	15.72	12.9	12.33	11.43	14.36	6.58	10.76	7.5	18.76	32.41	1.94	5.2	5.56
EBITDA-CapEx/Interest Expense	11.59	12.12	14.69	11.73	11.08	9.75	12.62	4.95	9.2	5.59	16.66	29.8	0.18	4.26	4.57
EBIT to Interest Expense	10	11.22	11.57	9.93	10.82	11.56	11.08	5.11	4.65	6.57	18.36	30.79	2	4.83	6.52
Interest Expense	1,681	1,522	1,414	1,360	1,199	1,186	1,270	1,316	1,573	1,449	1,291	1,238	2,209	3,091	2,671
Common Equity/Total Assets	43.69	43.71	44.32	42.53	38.65	34.68	41.49	39.76	37.67	41	42.54	48.51	39.3	41.33	41.54
Long-Term Debt/Equity (%)	42.27	38	39.76	44.04	42.23	50.8	45.59	50.86	54.61	56.04	44.87	33.28	67.76	64.07	70.07
Long-Term Debt/Capital (%)	28.73	26.05	26.93	29.12	26.75	30.13	28.59	30.88	30.32	34.96	30.37	24.41	37.78	37.27	40.34
Long-Term Debt/Total Assets (%)	18.58	16.7	17.7	18.82	16.4	17.71	19.01	20.34	20.67	23.06	19.15	16.19	26.71	26.57	29.21
Total Debt/Equity (%)	47.13	45.86	47.62	51.22	57.86	68.62	59.46	64.72	80.13	60.3	47.76	36.34	79.34	71.92	73.71
Total Debt/Capital (%)	32.03	31.44	32.26	33.87	36.65	40.69	37.29	39.29	44.48	37.62	32.32	26.66	44.24	41.83	42.43
Total Debt/Total Assets (%)	20.71	20.16	21.2	21.89	22.47	23.93	24.8	25.88	30.34	24.82	20.39	17.68	31.28	29.83	30.73
Net Debt to Equity	43.28	33.52	44.77	46.55	52.25	64.28	57.59	62.93	78.36	57.49	45.25	35.91	76.15	70.74	72.39
Net Debt/Capital (%)	30.21	25.11	30.93	31.76	34.32	39.13	36.54	38.63	43.93	36.5	31.15	26.42	43.23	41.43	41.99
EBITDA	21,364	19,861	22,234	17,538	14,784	13,561	18,241	8,656	16,930	10,871	24,214	40,126	4,294	16,087	14,839
EBITDA-CapEx	19,482	18,442	20,769	15,955	13,288	11,562	16,024	6,520	14,466	8,106	21,503	36,890	387	13,178	12,210
Operating Income (Loss)	16,808	17,074	16,366	13,499	12,976	13,710	14,073	6,730	7,311	9,513	23,704	38,117	4,417	14,938	17,407

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.92	1.11	1.39	1.67	0.79	0.57	0.66	0.59	0.26	0.47	0.73	0.54	0.27	0.48	0.37
Current Ratio	2.1	2.22	2.41	2.58	1.49	1.25	1.35	1.57	0.88	1.35	1.4	1.22	0.91	1.17	1.16
Quick Ratio	1.69	1.48	1.79	2.18	1.16	0.94	1.03	0.95	0.51	0.9	1.1	0.88	0.59	0.82	0.8
CFO/Avg Current Liab	0.7	0.58	0.67	0.76	0.58	0.54	0.55	0.51	0.36	0.46	0.95	0.69	0.19	0.28	0.29
Common Equity/Total Assets	43.69	43.71	44.32	42.53	38.65	34.68	41.49	39.76	37.67	41	42.54	48.51	39.3	41.33	41.54
Long-Term Debt/Equity (%)	42.27	38	39.76	44.04	42.23	50.8	45.59	50.86	54.61	56.04	44.87	33.28	67.76	64.07	70.07
Long-Term Debt/Capital (%)	28.73	26.05	26.93	29.12	26.75	30.13	28.59	30.88	30.32	34.96	30.37	24.41	37.78	37.27	40.34
Long-Term Debt/Total Assets (%)	18.58	16.7	17.7	18.82	16.4	17.71	19.01	20.34	20.67	23.06	19.15	16.19	26.71	26.57	29.21
Total Debt/Equity (%)	47.13	45.86	47.62	51.22	57.86	68.62	59.46	64.72	80.13	60.3	47.76	36.34	79.34	71.92	73.71
Total Debt/Capital (%)	32.03	31.44	32.26	33.87	36.65	40.69	37.29	39.29	44.48	37.62	32.32	26.66	44.24	41.83	42.43
Total Debt/Total Assets (%)	20.71	20.16	21.2	21.89	22.47	23.93	24.8	25.88	30.34	24.82	20.39	17.68	31.28	29.83	30.73
CFO/Total Liabilities	19.21	16.08	18.52	17.81	14.35	14.49	16.78	16.54	12.09	15.87	31.32	28.89	6.34	10.2	9.64
CFO/CapEx	10.75	11.8	12.07	10.79	9.82	8.1	7.58	7.41	5.11	5.21	12.02	9.04	2.23	4.38	4.45
Altman's Z-Score	- -	- -	3.92	3.85	3.85	4.27	4.74	4.51	3.54	4.11	4.9	5.73	3.2	3.91	4.16

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.41	4.61	5.15	5.59	5.89	6.44	6.39	5.03	5.53	5.67	8.38	9.02	5.29	5.53	5.36
Days Sales Outstanding	82.74	79.24	70.87	65.33	61.93	56.66	57.12	72.62	66.02	64.34	43.54	40.46	69.01	66.05	68.06
Inventory Turnover	1.67	1.55	1.57	1.62	1.46	1.72	1.56	1.19	1.11	1.12	3.61	3.81	2.6	1.7	1.49
Days Inventory Outstanding	219.22	235.74	233.07	225.41	249.24	211.74	233.42	306.35	330.29	324.56	101.13	95.86	140.2	215.1	244.27
Accounts Payable Turnover	2.78	2.81	3.14	2.82	3.37	2.84	2.62	1.91	1.78	2.31	6.46	5.53	3.87	3	2.92
Accounts Payable Turnover Days	131.34	129.68	116.09	129.6	108.41	128.4	139.53	190.95	205.2	158.01	56.49	65.97	94.31	121.68	125.04
Cash Conversion Cycle	170.62	185.31	187.85	161.14	202.76	140	151.02	188.02	191.1	230.89	88.18	70.35	114.9	159.48	187.29
Inventory to Cash Days	-136.48	-156.49	-162.19	-160.08	-187.31	-155.07	-176.3	-233.73	-264.27	-260.21	-57.59	-55.4	-71.19	-149.05	-176.21
Inventories	6,610	6,076	6,166	5,663	7,513	6,783	7,578	7,508	7,068	8,020	9,059	8,981	10,189	10,851	10,654
Raw Materials	785	448	505	510	867	793	788	546	672	716	994	859	1,007	976	907
Work In Process	3,514	3,374	3,445	3,248	3,932	3,696	3,908	4,701	4,131	4,436	4,424	5,519	5,688	6,101	5,634
Finished Goods	2,311	2,254	2,216	1,905	2,714	2,293	2,883	2,262	2,265	2,867	3,641	2,603	3,495	3,775	4,113
Other Inventory	- -	- -	- -	- -	- -	1	-1	-1	- -	1	- -	- -	-1	-1	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	194,871	197,049	202,881	195,904	216,730	246,621	215,146	203,959	324,685	285,421	160,652	149,519	142,528
- Cash & Cash Equivalents	3,182	10,081	2,183	3,343	3,641	2,595	1,342	1,139	1,121	1,786	1,944	416	2,853	1,043	1,142
+ Preferred Equity and Hybrid Capital	45	39	33	29	26	24	21	19	17	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	431	418	313	321	278	296	348	351	303	235	262	256	274	294	299
+ Total Debt	38,942	37,460	36,489	36,682	37,605	41,062	42,606	41,265	50,840	38,274	36,998	34,859	70,845	63,649	63,961
Enterprise Value	- -	- -	199,298	197,959	217,500	219,436	239,713	269,423	256,660	230,245	330,876	297,804	219,081	192,985	193,192
Total Capital	121,563	119,138	113,109	108,304	102,603	100,902	114,262	105,023	114,287	101,747	114,460	130,775	160,133	152,146	150,736
Total Debt/Capital (%)	32.03	31.44	32.26	33.87	36.65	40.69	37.29	39.29	44.48	37.62	32.32	26.66	44.24	41.83	42.43
Total Debt / EV	- -	- -	0.18	0.19	0.17	0.19	0.18	0.15	0.2	0.17	0.11	0.12	0.32	0.33	0.33
EV/Sales	- -	- -	3.86	3.99	4.45	4.15	4.56	6.6	6.27	5.53	4.07	2.94	3.68	3.03	3.09
EV/EBITDA	- -	- -	8.96	11.29	14.71	16.18	13.14	31.13	15.16	21.18	13.66	7.42	51.02	12	13.02
EV/EBIT	- -	- -	12.59	16.5	22.59	28.12	20.02	107.51	22.97	37.2	17.39	8.49	- -	21.27	23.43
EV/Cash Flow to Firm	- -	- -	10.65	10.94	13.92	12.74	- -	- -	18.23	14.59	9.8	9.8	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	11.56	11.99	15.4	14.42	- -	- -	22.1	17.7	10.65	10.97	- -	- -	- -
Diluted Market Cap	- -	- -	209,976	201,215	205,575	198,776	219,593	257,837	220,628	206,341	329,769	291,367	162,445	150,390	143,205
Diluted Enterprise Value	- -	- -	214,403	202,125	220,194	222,308	242,576	280,639	262,142	232,627	335,960	303,750	220,874	193,856	193,869
EV per Share	- -	- -	7.83	7.91	8.85	9.08	10.07	11.84	11.65	10.39	14.79	13.33	9.75	8.56	8.54
TTM Sales	61,035	54,657	51,584	49,605	48,851	52,824	52,546	40,825	40,905	41,651	81,288	101,175	59,554	63,627	62,579
TTM EBITDA	21,364	19,861	22,234	17,538	14,784	13,561	18,241	8,656	16,930	10,871	24,214	40,126	4,294	16,087	14,839
TTM Operating Income	16,808	17,074	16,366	13,499	12,976	13,710	14,073	6,730	7,311	9,513	23,704	38,117	4,417	14,938	17,407
TTM Cash Flow to Firm	21,391	17,967	18,711	18,097	15,621	17,219	- -	- -	14,080	15,776	33,773	30,386	- -	- -	- -
TTM Free Cash Flow to Firm	19,509	16,548	17,246	16,514	14,125	15,220	- -	- -	11,616	13,011	31,062	27,150	- -	- -	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	12.95	12.98	15.58	14.01	15.06	18.83	21.79	17.73	11.04	11.19	33.89	15.29	15.78
EV/EBIT	- -	- -	12.59	16.5	22.59	28.12	20.02	107.51	22.97	37.2	17.39	8.49	- -	21.27	23.43
Enterprise Value	- -	- -	199,298	197,959	217,500	219,436	239,713	269,423	256,660	230,245	330,876	297,804	219,081	192,985	193,192
Low Price	- -	- -	7.07	6.95	7.6	7.2	7.76	8.4	8.59	7.02	8.22	10.2	6.51	6.17	5.33
EV/Sales	- -	- -	3.86	3.99	4.45	4.15	4.56	6.6	6.27	5.53	4.07	2.94	3.68	3.03	3.09
EV/EBITDA	- -	- -	8.96	11.29	14.71	16.18	13.14	31.13	15.16	21.18	13.66	7.42	51.02	12	13.02
Price/Earnings	- -	- -	9.43	21.76	29.16	27.24	10.16	22.71	13.51	22.22	14.72	9.08	75.77	18.61	18.33
Price/Earnings Average	- -	- -	9.39	21.27	29.82	27.5	9.55	20.53	13.9	22.16	10.69	8.86	97.99	19.62	18.06
Price/Earnings High	- -	- -	9.95	24.06	32.04	31.32	10.42	24.12	15.26	26.13	15.6	10.42	138.31	22.42	20.19
Price/Earnings Low	- -	- -	8.71	19.21	26.86	24.19	8.66	17.59	11.88	16.95	8.33	7.26	68.97	17.31	15.52
Price/Book Value	- -	- -	2.55	2.76	3.14	3.29	3.04	3.89	3.41	3.23	4.21	2.98	1.8	1.7	1.65
Price/Book Value Average	- -	- -	2.54	2.7	3.21	3.32	2.86	3.52	3.51	3.22	3.05	2.91	2.33	1.79	1.62
Price/Book Value High	- -	- -	2.7	3.06	3.45	3.78	3.12	4.13	3.85	3.79	4.46	3.42	3.29	2.04	1.82
Price/Book Value Low	- -	- -	2.36	2.44	2.89	2.92	2.59	3.01	3	2.46	2.38	2.38	1.64	1.58	1.4
Price/Tangible Book Value	- -	- -	-34.61	-33.04	-8.49	-4.12	-6.49	-9.77	-11.32	-13.92	114.08	311.94	-3.68	-4.18	-3.7
Price/Tangible Book Value Average	- -	- -	-34.47	-32.29	-8.68	-4.16	-6.1	-8.83	-11.65	-13.88	82.86	304.33	-4.76	-4.41	-3.65
Price/Tangible Book Value High	- -	- -	-36.53	-36.53	-9.33	-4.73	-6.66	-10.38	-12.78	-16.36	120.85	357.61	-6.72	-5.04	-4.08
Price/Tangible Book Value Low	- -	- -	-31.98	-29.16	-7.82	-3.66	-5.53	-7.57	-9.95	-10.62	64.56	249.19	-3.35	-3.89	-3.13
Price/Sales	- -	- -	4.02	4.01	4.15	3.72	4.12	6.2	5.29	4.89	3.98	2.82	2.7	2.35	2.28
Price/Sales Average	- -	- -	4.01	3.92	4.25	3.76	3.87	5.61	5.45	4.87	2.89	2.75	3.49	2.48	2.24
Price/Sales High	- -	- -	4.24	4.43	4.56	4.28	4.23	6.59	5.98	5.74	4.22	3.23	4.92	2.83	2.51
Price/Sales Low	- -	- -	3.72	3.54	3.83	3.3	3.51	4.81	4.65	3.73	2.25	2.25	2.45	2.19	1.93
Price/Cash Flow	- -	- -	11.73	11.63	13.81	12.14	12.88	16	17.2	14.13	9.93	9.74	18.46	11.73	12.17
Price/Cash Flow Average	- -	- -	11.68	11.37	14.13	12.25	12.11	14.46	17.7	14.09	7.21	9.5	23.87	12.36	11.99
Price/Cash Flow High	- -	- -	12.38	12.86	15.18	13.96	13.22	16.99	19.43	16.61	10.52	11.16	33.69	14.13	13.41
Price/Cash Flow Low	- -	- -	10.84	10.27	12.72	10.78	10.98	12.4	15.12	10.78	5.62	7.78	16.8	10.91	10.3
Price/Free Cash Flow Average	- -	- -	12.89	12.69	15.94	14.14	14.16	17.02	22.43	17.68	8.02	10.92	43.83	16.12	15.55
Price/Free Cash Flow High	- -	- -	13.66	14.35	17.12	16.1	15.45	20	24.62	20.85	11.69	12.83	61.86	18.42	17.38
Price/Free Cash Flow Low	- -	- -	11.96	11.46	14.35	12.43	12.83	14.59	19.16	13.52	6.25	8.94	30.85	14.23	13.36
EV/Sales Average	- -	- -	3.85	3.9	4.55	4.19	4.32	6.02	6.43	5.52	2.98	2.87	4.47	3.16	3.05
EV/Sales High	- -	- -	4.07	4.41	4.86	4.71	4.67	6.97	6.96	6.39	4.31	3.36	5.91	3.51	3.32
EV/Sales Low	- -	- -	3.58	3.52	4.12	3.74	3.95	5.24	5.64	4.37	2.34	2.38	3.44	2.87	2.74
EV/EBITDA Average	- -	- -	8.93	11.03	15.02	16.32	12.44	28.38	15.53	21.13	9.99	7.25	61.99	12.5	12.88
EV/EBITDA High	- -	- -	9.45	12.47	16.07	18.35	13.45	32.89	16.81	24.48	14.46	8.46	81.9	13.9	13.99
EV/EBITDA Low	- -	- -	8.3	9.97	13.63	14.56	11.39	24.7	13.62	16.73	7.84	5.99	47.66	11.35	11.54
EV/EBIT Average	- -	- -	12.54	16.12	23.07	28.35	18.95	98.04	23.53	37.11	12.72	8.3	- -	22.16	23.17
EV/EBIT High	- -	- -	13.28	18.23	24.68	31.88	20.5	113.59	25.46	42.99	18.41	9.69	- -	24.64	25.18
EV/EBIT Low	- -	- -	11.66	14.57	20.93	25.3	17.35	85.33	20.64	29.38	9.98	6.86	- -	20.12	20.77
Last Price	- -	- -	7.65	7.87	8.26	8.11	9.11	10.84	9.77	9.21	14.52	12.77	7.15	6.63	6.3
High Price	- -	- -	8.08	8.7	9.07	9.33	9.35	11.51	11.04	10.82	15.38	14.64	13.05	7.99	6.94
Enterprise Value Average	- -	- -	198,498	193,508	222,115	221,272	226,828	245,682	262,917	229,711	242,009	290,845	266,185	201,083	191,091
Enterprise Value High	- -	- -	210,083	218,756	237,571	248,791	245,414	284,657	284,547	266,087	350,123	339,596	351,670	223,604	207,666
Enterprise Value Low	- -	- -	184,455	174,839	201,485	197,463	207,695	213,838	230,636	181,860	189,938	240,388	204,653	182,579	171,307

Shares Outstanding	30,144	28,954	25,464	25,034	24,573	24,155	23,793	22,750	22,022	22,153	22,364	22,348	22,468	22,551	22,627
Diluted Weighted Avg Shares	31,318	29,877	27,438	25,564	24,899	24,509	24,107	23,785	22,583	22,412	22,714	22,814	22,718	22,683	22,734
Basic Weighted Avg Shares	31,107	29,615	27,112	25,253	24,577	24,231	23,757	23,367	22,161	22,106	22,289	22,317	22,456	22,539	22,615
Revenue per Share	1.96	1.85	1.9	1.96	1.99	2.18	2.21	1.75	1.85	1.88	3.65	4.53	2.65	2.82	2.77
EBITDA per Share	0.69	0.67	0.82	0.69	0.6	0.56	0.77	0.37	0.76	0.49	1.09	1.8	0.19	0.71	0.66
Operating Income per Share	0.54	0.58	0.6	0.53	0.53	0.57	0.59	0.29	0.33	0.43	1.06	1.71	0.2	0.66	0.77
Basic EPS, GAAP	0.32	0.49	0.81	0.36	0.28	0.3	0.9	0.48	0.72	0.41	0.99	1.41	0.09	0.36	0.34
Basic EPS from Cont Ops	0.25	0.3	0.42	0.36	0.28	0.3	0.9	0.17	0.48	0.3	1.01	1.41	0.1	0.36	0.34
Diluted EPS, GAAP	0.32	0.49	0.8	0.36	0.28	0.29	0.88	0.47	0.71	0.41	0.97	1.38	0.09	0.35	0.34
Diluted EPS from Cont Ops	0.25	0.3	0.42	0.36	0.28	0.29	0.89	0.16	0.48	0.3	0.99	1.38	0.1	0.35	0.34
Dividend per Share	0.2	0.22	0.24	0.26	0.28	0.3	0.32	0.34	0.36	0.38	0.39	0.4	0.41	0.42	0.43
Cash Flow per Share	0.65	0.57	0.65	0.68	0.6	0.67	0.71	0.68	0.57	0.65	1.46	1.31	0.39	0.57	0.52
Free Cash Flow per Basic Share	0.59	0.52	0.6	0.61	0.54	0.59	0.61	0.59	0.46	0.53	1.34	1.17	0.21	0.44	0.4
Cash & Equivalents per Share	0.88	1.12	1.27	1.44	0.95	0.74	0.84	0.83	0.44	0.55	1.39	1.02	0.56	0.91	0.6
Book Value per Share	2.73	2.81	3	2.85	2.63	2.46	3	2.79	2.87	2.85	3.45	4.28	3.96	3.91	3.82
Tangible Book Value per Share	-0.45	-0.26	-0.22	-0.24	-0.97	-1.97	-1.4	-1.11	-0.86	-0.66	0.13	0.04	-1.94	-1.58	-1.7

Pfizer, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)